Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study.

Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42765974

Christina M Shay; Deborah J Wexler; Elisabetta Patorno; Hanseul Cho; Helen Tesfaye; Janinne Ortega-Montiel; Julie M Paik; Niklas Schmedt; Sara J Cromer

Sep 22, 2026